We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.135 | 0.13 | 0.14 | 0.135 | 0.135 | 0.14 | 104,139 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2020 15:12 | Looks like we may get some positive news on ODM in veterinary medicine. Dedicated website set up for small animals with a case study from Cornell See www.deltexveterinary Big market potential: just think of people's horror at the size of bills for per surgery so a little extra to help Fido live longer and better is not much of an ask especially if insurer picks up the tab | schloo | |
08/9/2020 09:32 | Hi mrC2u, still agree with the fact the changes are needed here, however LID has lost over 20% in value over the last 3-4 weeks so much for HUP!! | gbenson1 | |
08/9/2020 08:58 | Second half of this month. They have to put them out within 90 days but tend to be very slow these days. Suspect they are waiting as long as possible to see if anything good happens, like a resurgence from a surge in surgeryBetter to get on with it, get them out and get on with the things they should be doing:New chairNew, smaller boardNew advisersNew monitorNew commercial modelNew marketing storyDoubt any of this will happen and expect the corinavirus will be blamed for everything rather than being seized as a wonderful opportunity to reinvent, relaunch and reinvigorateAt the risk of droning on, LID did all the New stuff and also took advantage of the pandemic. That is why their H1 sales are FOUR times DEMG's when they were neck and neck two years agoAnd I apologize for not answering your question: don't know date, why don't you ask the company?MrC | mrc2u | |
03/9/2020 13:22 | When do 1st half results come out? | janatha | |
24/8/2020 12:32 | Suspect Lidco are holding estimates back to allow for future upgrades- however there are clearly sceptics out there as LID is on a big discount to DEMG on EV/Sales basis | vega44 | |
24/8/2020 12:18 | Hats of to LID, they took real advantage. But note, if new broker estimates for LID were seen to be correct, then sales in H 2 will fall to £3.5m and the H2 loss would be £0.8m. | sidam | |
24/8/2020 08:11 | Well done to LID for a very strong first half. They have taken full advantage of the CoVid gift horse and GROWN their core product sales by 83% to 6.1mDEMG, on the other hand, somehow managed to totally miss the gift horse and saw (yet another) sharp decline in sales to 1.2mFrom parity with LID in 2017 to selling less than one fifth two and a half years later is a truly dreadful performance by DEMGHeads must roll and they must roll now. Absolutely shocking and heaven only knows what this will do to the relative share pricesTerrible start to the week. Although glad I bought a few LID at half the current priceMrC | mrc2u | |
24/8/2020 07:30 | H1 revs: DEMG £1.2m vs LID £6.2m | vega44 | |
11/8/2020 19:22 | Lidco update probably a few days off- that will give an indication of the prevailing UK market shares for LID and DEMG | vega44 | |
11/8/2020 12:14 | Thank you. Suggests Europe running at 67% of normal and US at 90%. That would be ok in a growing business and if sustained but worry must be that DEMG's business in Europe will only get back to 50% given down trend recentlyEven at 67 & 90 they will need to reduce costs. Your guys mention 20% cuts in directors' remuneration but not heard anything similar from DEMG MrC (back to paddling pool now) | mrc2u | |
11/8/2020 11:18 | You could look at the AGM statement of RUA life sciences. It talks about the recovery in elective surgery. | sidam | |
11/8/2020 10:07 | I haven't sold any (yet) but will do post interims if another fundraise looks likely. If nothing else, enough to enable me to take up discounted rights when the call comesAgree re big company and still believe that this could still be sold within a year at north of 10p a share. Just can't see any evidence that the current board will get on with itMrC | mrc2u | |
11/8/2020 09:53 | Hi mrC2u, whilst I can't agree that DEMG are showing signs of a sell, I do agree with some of your observations! DEMG is grossly undervalued at the moment and I expect a 2.30p Sp would be fair value. The company need a bright professional CEO with the highest Medical background and not someone who has come through the ranks and was a cheap alternative. I believe another way to realise the true value of the technology is for a larger company to take over DEMG and give it the backing/promotion it deserves to realise it's true potential. A new driven advisor would in part get DEMGs proven and tested equipment to a wider audience. With the recent large placing @1p perhaps a consolidation of the Sp to say 1 for 5 or 1 for 10 may help in the markets. A bid premium of 7-8p per share would not be excessive. | gbenson1 | |
11/8/2020 09:10 | That would involve a return to normal levels of major surgery which seems highly unlikely between now and the end of the yearAlso don't forget that DEMG have been losing sales for the last two or three years anyway so, at best, are going to bounce back to a lower level of surgical cases than before even if things return to normalThis means they will have to reduce costs again which makes it less likely they will be able to maintain market share let alone grow if and when things get back to normal And they aren't going to grow until they have:- a new monitor (10 years and counting)- a new commercial model (which needs a new monitor anyway)- a new marketing story (and they seem to have missed the open goal from CoVid)Afraid can't see them doing the above until they have a new chair and a new board. They will also need new advisers to help them raise the new money they need to launch the new monitorIf they can survive that long. Starting to worry that they will need a new bail out maybe even this halfWould be interested to hear from one of the buyers why they are buying now when all the signs are suggesting it's time to sellMrC | mrc2u | |
11/8/2020 08:41 | Hoping that the H2 rebound materialises...... | chrisdgb | |
06/8/2020 23:33 | Nice buying momentum coming through, single 500k yesterday and late reported 1,000,000 after the close today, unfortunately Sp hasn't moved!! Will we get another MS TR-1 in the coming weeks? | gbenson1 | |
03/8/2020 11:11 | I bought a lot when it went down below 0.8 and a massive amount in the placing at 1.25p. My average now is about at the current level which is a result! | nobbygnome | |
03/8/2020 11:05 | If I remember rightly you're like me, a holder from way back circa 24p hope you grabbed plenty @ 1p | gbenson1 | |
03/8/2020 10:57 | So he now has 26 million shares which is an impressive holding. I must admit it influences my thoughts about the company and I am considering buying some more...... | nobbygnome | |
03/8/2020 09:53 | Michael Stubbs has added another circa 6,000,000 shares in the last 11 months, his holding is now 5% of the whole issued share capital, my guess is he's the 500k man!! All of the recent holdings RNSs are people increasing their holdings, onwards and upwards. Sorry, but off topic I see loserco have issued 0, zilch, nada, options in the management incentive scheme!! | gbenson1 | |
31/7/2020 16:31 | >>gbensonAfraid I will be keeping my attention over here as I have as many millions of DEMG as I do hundreds of thousands of LIDHave done my homework on the two core technologies and think DEMG's works and LID's doesn't. Therefore keen to understand how DEMG have fallen so far behind in two years that they will not sell as much in the whole year as LID did in the first quarter I get that LID have a monitor to sell to hospitals and DEMG have one to sell to museums but that is within DEMG's control, surely? They have been working on a new one for at least a decade and I, and many others, have put in new cash at least twice to fund one. Where on earth is it???The conclusion must be that LID are doing something right and, lo and behold, it turns out they have actually being doing the things I have been droning on as needing doing by DEMGOnce DEMG have done them, it will be a far better investment IMHO but getting desperate to see urgency and not more facile upbeat platitudes in every updateOff to sit in the paddling poolMrC | mrc2u | |
31/7/2020 16:05 | Credit where it’s due - Deltex have a remarkable job expanding their revenue multiple over the period while Lidco’s has gone down | vega44 | |
31/7/2020 15:54 | mrC2u & Vega44 I think you need to concentrate your efforts on your beloved Loserco bored!! down again for another day. | gbenson1 | |
31/7/2020 15:46 | Next week or week after for LID update?From parity to 3x in 3 years is a remarkable achievementSadly, probably more remarkable for DEMG than LID, but LID have done basics and got:New chairNew, slim, boardNew advisersNew commercial modelNew marketing storyNew box"Simples" as that nice Mrs May once saidAnd DEMG have done none of the aboveMustn't get hot under the collar thoughMrC | mrc2u | |
31/7/2020 15:34 | I think we’ll have to wait for the Lidco results to find out. Their blow out Q1 was based on monitor sales into ICU, the next question is how that enlarged installed base will convert into recurring revenues. N+1 are at £9m for Lidco this year while the estimate for Deltex must be around £3m based on H1 | vega44 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions